DP009 | THE PROGNOSTIC ROLE OF DEL 9P21.3 (CDKN2A) IN PATIENTS WITH MANTLE CELL LYMPHOMA. RESULTS FROM THE FIL_MANTLE-FIRST BIO STUDY.

Mantle Cell Lymphoma (MCL) is an aggressive malignancy with variable clinical behaviour, largely reflecting its molecular heterogeneity. The genomic landscape of MCL encompasses gene mutations with strong prognostic implications (i.e., TP53, NOTCH1/2, KMT2D, etc), and secondary genetic events such...

Celý popis

Podrobná bibliografie

Hlavní autoři:	M.E. Carazzolo, F.M. Quaglia, A. Aparo, A. Parisi, R. Moia, F. Piazza, A. Re, M.C. Tisi, M. Ciceri, P. Bulian, A. Castellino, V.R. Zilioli, P.M. Stefani, A. Fabbri, E. Lucchini, A. Arcari, L. Lorenzi, B. Famengo, M. Ponzoni, A. Ferrari, S. Ragaini, J. Olivieri, M.T. Scupoli, V. Salaorni, S. Gambino, M. Galasso, C. Visco
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Ferrata Storti Foundation 2025-09-01
Edice:	Haematologica
On-line přístup:	https://haematologica.org/article/view/12773
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!